title: Intellectual property. Challenges to India's pharmaceutical patent laws.
authors: Health Policy and Management, Columbia University, New York, NY 10032, USA. bns3@columbia.edu
authors: Bhaven N
authors: BN
authors: Sampat
authors: Kenneth C
authors: KC
authors: Shadlen
authors: Tahir M
authors: TM
authors: Amin
mesh_terms: D001549:Benzamides; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D000068877:Imatinib Mesylate; D007194:India; D007391:International Cooperation; D007603:Jurisprudence; D007880:Legislation, Drug; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D010879:Piperazines; D011743:Pyrimidines; D014481:United States
chemical_list: D001549:Benzamides; D016568:Drugs, Generic; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate